Chemoinformaics analysis of 1,2-epoxy-tridec-1-ene-5,7,9,11-tetrayne
| Molecular Weight | 200.237 | nRot | 3 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 4 |
| Exact Molecular Weight | 200.084 | nRing | 0 |
| Solubility: LogS | -2.82 | nHRing | 0 |
| Solubility: LogP | 2.851 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 31.3155 |
| nHD | 2 | BPOL | 12.0385 |
| QED | 0.637 |
| Synth | 4.21 |
| Natural Product Likeliness | 2.208 |
| NR-PPAR-gamma | 0.828 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.001 |
| HIA | 0.984 |
| CACO-2 | -4.741 |
| MDCK | 0.000428951 |
| BBB | 0.005 |
| PPB | 1.02833 |
| VDSS | 1.18 |
| FU | 0.0250687 |
| CYP1A2-inh | 0.912 |
| CYP1A2-sub | 0.099 |
| CYP2c19-inh | 0.849 |
| CYP2c19-sub | 0.527 |
| CYP2c9-inh | 0.867 |
| CYP2c9-sub | 0.941 |
| CYP2d6-inh | 0.039 |
| CYP2d6-sub | 0.509 |
| CYP3a4-inh | 0.597 |
| CYP3a4-sub | 0.125 |
| CL | 11.217 |
| T12 | 0.456 |
| hERG | 0.001 |
| Ames | 0.841 |
| ROA | 0.786 |
| SkinSen | 0.957 |
| Carcinogencity | 0.638 |
| EI | 0.982 |
| Respiratory | 0.8 |
| NR-Aromatase | 0.954 |
| Antiviral | No |
| Prediction | 0.598586 |